Implementation of DNA cytometric measurements in fine-needle aspiration biopsy diagnostics of breast disease

Cancer

Volumn 102, Issue 6, 2004, Pages 380-388

  Elzagheid, Adem ^a   Kuopio, Teijo ^b   Collan, Yrjo ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

Breast carcinoma; Breast lesions; DNA cytometry; Fine needle aspiration biopsy

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CELL SEPARATION; CONTROLLED STUDY; CYTOMETRY; DIAGNOSTIC PROCEDURE; DIPLOIDY; FEULGEN STAINING; HISTOGRAM; HUMAN; HUMAN TISSUE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; FEMALE; HUMANS; IMAGE CYTOMETRY; PLOIDIES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 10244266292     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20641     Document Type: Article

References (28)

1. Grosby JH. The role of fine needle aspiration biopsy in the diagnosis and management of palpable masses. J Med Assoc GA. 1996;1:33-36.
2. Verkooijen HM, Peeters PH, Borel Rinkes IH, et al. Risk factors for cancellation of stereotactic large core needle biopsy on a prone biopsy table. Br J Radiol. 2001;74:1007-1012.
3. Böcking A, Giroud F, Reith A. Consensus report of the European Society for Analytical Cellular Pathology task force on standardization of diagnostic DNA image cytometry. Anal Quant Cytol Histol. 1995;17:1-7.
4. Auer GU, Caspersson TO, Wallgren AS. DNA content and survival in mammary carcinoma. Anal Quant Cytol. 1980;2:161-165.
5. Böcking A, Chatelain R, Biesterfeld S, et al. DNA grading of malignancy in breast cancer. Prognostic validity, reproducibility and comparison with other classifications. Anal Quant Cytol Histol. 1989;2:73-80.
6. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer. Int J Clin Oncol. 2001;6:177-182.
7. Elzagheid A, Collan Y. Dependence of DNA-histograms on the sampling techniques in fine needle aspirates of the breast. Anal Cell Pathol. 2002;24:159-165.
8. Gaub J, Auer GU, Zetterberg A. Quantitative cytological aspects of a combined Feulgen naphthol yellow S staining procedure for the simultaneous determinants of nuclear and cytoplasmic protein and DNA in mammalian cells, Exp Cell Res. 1975;92:323-332.
9. Elzagheid A, Kuopio T, Korhonen AM, Collan Y. Apocrine change in fine-needle aspiration biopsy: nuclear morphometry and DNA image cytometry. APMIS. 2003;111:898-904.
10. Elzagheid A, Collan Y. Fine needle aspiration biopsy: value of nuclear morphometry after different sampling methods. Anal Quant Cytol Histol. 2003;25:73-80.
11. Bibbo M. Comprehensive cytopathology, 2nd ed. Philadelphia: W.B. Saunders Company, 1997.
12. Stenbäck F, Koivuniemi A. General cytology. In: Koivuniemi A, editor. Kliininen sytologia [in Finnish]. Helsinki: Kandidaattikustannus 1994:12-15.
13. Buhmeida A, Kuopio T, Collan Y. Nuclear size and shape in fine needle aspiration biopsy samples of the prostate. Anal Quant Cytol Histol. 2000;22:291-298.
14. Rosen P. Rosen's breast pathology, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2001.
15. Tavassoli F, Devillee P. WHO classification of tumours, pathology and genetics, tumours of the breast and female genital organs. Lyon: IARC Press, 2003.
16. Haroske G, Baak JP, Danielsen H, et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol. 2001;23:89-95.
17. Teague MW, Wolberg WH, Nick Street W, Mangsarian OL, Lambremont S, Page DL. Indeterminate fine needle aspiration of the breast. Cancer (Cancer Cytopathol). 1997;81:129-135.
18. Auer G, Askensten U, Ahrens O. Cytophotometry. Hum Pathol. 1997;20:518-527.
19. Fallenius AG, Auer GU, Carstensen JM. Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer. 1988;62:331-341.
20. Ludwig AS, Okagaki T, Richart RM, Lattes R. Nuclear DNA content of lobular carcinoma in situ of the breast. Cancer. 1973;31:1553-1560.
21. Ruiz-Sauri A, Almenar-Medina S, Callaghan RC, Calderon J, Llombart-Bosch A. Radial scar versus tubular carcinoma of the breast. A comparative study with quantitative techniques (morphometry, image- and flow cytometry). Pathol Res Pract. 1995;191:547-554.
22. Mitelman F. Nature encyclopedia of the human genome. London: Macmillan Publisher Ltd., Nature Publishing Group, 2003.
23. Frei JV, Martinez VJ. Aneuploidy in nonneoplastic and benign melanocytic and breast lesions determined by DNA flow cytometry. Mod Pathol. 1992;5:600-602.
24. Izuo M, Okagaki T, Richart RM, Lattes R. Nuclear DNA content in hyperplastic lesions of cystic disease of the breast with special reference to malignant alteration. Cancer. 1971;28:620-627.
25. Vogelbruch M, Rutten A, Böcking A, Kapp A, Kiehl P. Differentiation between malignant and benign follicular adnexal tumours of the skin by DNA image cytometry. Br J Dermatol. 2002;146:238-243.
26. Carpenter R, Gibbs N, Matthews J, Cooke T. Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast. Br J Surg. 1987;74:905-906.
27. Ruiz A, Almenar S, Callaghan RC, Llombart-Bosch A. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry. Pathol Res Pract. 1999;195:741-746.
28. Weiss H, Wildner GP, Gutz HJ, Ebeling K, Steinhoff G, Tanneberger S. DNA distribution patterns of preneoplastic cells and their interpretation. Stomach and cervix uteri. Oncology. 1981;38:210-218.